{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:10:42Z","timestamp":1760404242055},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1989,6]]},"DOI":"10.1007\/bf00444696","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T08:18:50Z","timestamp":1100161130000},"page":"231-235","source":"Crossref","is-referenced-by-count":19,"title":["Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal"],"prefix":"10.1007","volume":"98","author":[{"given":"Mark S.","family":"Kleven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon B.","family":"Sparber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"127","volume":"11","author":"D Bellini","year":"1982","unstructured":"Bellini D, Calvani M, Fenelli A, Le Pera G, Pietrini U, Sicuteri F (1982) Serotonin precursor (L-5-HTP) alleviates, the abstinence syndrome in morphine-heroin addicts. Int J Clin Pharmacol Res 11:127?133","journal-title":"Int J Clin Pharmacol Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0014-2999(71)90034-3","volume":"16","author":"BA Berkowitz","year":"1971","unstructured":"Berkowitz BA, Spector S (1971) The effect of caffeine and theophylline on the disposition of brain serotonin in the rat. Eur J Pharmacol 16:322?325","journal-title":"Eur J Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0014-2999(70)90158-5","volume":"10","author":"BA Berkowitz","year":"1970","unstructured":"Berkowitz BA, Tarver JH, Spector S (1970) Release of norepinephrine in the central nervous system by theophylline, and caffeine. Eur J Pharmacol 10:64?71","journal-title":"Eur J Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(71)90033-1","volume":"16","author":"BA Berkowitz","year":"1971","unstructured":"Berkowitz BA, Spector S, Pool W (1971) The interaction of caffeine, theophylline and theobromine with monoamine oxidase inhibitors. Eur J Pharmacol 16:315?321","journal-title":"Eur J Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2999(78)90397-7","volume":"47","author":"DP Cardinali","year":"1978","unstructured":"Cardinali DP (1978) Effect of pentoxifylline and aminophylline on biogenic amine metabolism of the rat brain. Eur J Pharmacol 47:239?243","journal-title":"Eur J Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1210\/endo-100-3-692","volume":"100","author":"JA Clemens","year":"1975","unstructured":"Clemens JA, Sawyer BD, Cerimele B (1975) Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology 100:692?698","journal-title":"Endocrinology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000136467","volume":"11","author":"HOJ Collier","year":"1974","unstructured":"Collier HOJ (1974) The concept of the quasi-abstinence effect and its use in the investigation of dependence mechanisms. Pharmacology 11:58?61","journal-title":"Pharmacology"},{"key":"CR8","first-page":"1513","volume":"40","author":"HOJ Collier","year":"1981","unstructured":"Collier HOJ, Cuthbert NJ, Francis DL (1981) Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines. Fed Proc 40:1513?1518","journal-title":"Fed Proc"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0028-3908(83)90215-0","volume":"22","author":"FC Colpaert","year":"1983","unstructured":"Colpaert FC, Janssen PAJ (1983) The head-twich response to intra-peritoneal injection of 5-hydroxytryptophan in the rat. Antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. Neuropharmacology 22:993?1000","journal-title":"Neuropharmacology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(84)90206-1","volume":"103","author":"FC Colpaert","year":"1984","unstructured":"Colpaert FC, Janssen PAJ (1984) A possible alpha 2-adrenergic component in the in vivo activity of pirenperone. Eur J Pharmacol 103:169?171","journal-title":"Eur J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0014-2999(79)90326-1","volume":"58","author":"FC Colpaert","year":"1979","unstructured":"Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists. Eur J Pharmacol 58:505?509","journal-title":"Eur J Pharmacol"},{"key":"CR12","first-page":"206","volume":"221","author":"FC Colpaert","year":"1982","unstructured":"Colpaert FC, Niemegeers, CJE, Janssen PAJ (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221:206?214","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","first-page":"389","volume":"26","author":"E Contreras","year":"1980","unstructured":"Contreras E, Tamayo L, Quijada L, Munoz M (1980) Decrease of tolerance and physical dependence on morphine by drugs affecting brain serotonin. J Mol Biol 26:389?393","journal-title":"J Mol Biol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(83)90248-0","volume":"90","author":"LP Dwoskin","year":"1983","unstructured":"Dwoskin LP, Neal BS, Sparber SB (1983) Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats. Eur J Pharmacol 90:269?273","journal-title":"Eur J Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/0024-3205(75)90299-4","volume":"16","author":"DL Francis","year":"1975","unstructured":"Francis DL, Roy AC, Collier HOJ (1975) Morphine abstinence and quasi-abstinence, effects after phosphodiesterase inhibitors and naloxone. Life Sci 16:1901?1906","journal-title":"Life Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1471-4159.1983.tb12678.x","volume":"40","author":"MP Galloway","year":"1983","unstructured":"Galloway MP, Roth RH (1983a) Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain. J Neurochem 40:246?251","journal-title":"J Neurochem"},{"key":"CR17","first-page":"1","volume":"227","author":"MP Galloway","year":"1983","unstructured":"Galloway MP, Roth RH (1983b) Neuropharmacology of 3-isobutylmethyl-xanthine: effects on central noradrenergic systems in vivo. J Pharmacol Exp Ther 227:1?8","journal-title":"J Pharmacol Exp Ther"},{"key":"CR18","first-page":"277","volume":"173","author":"RG Graeff","year":"1970","unstructured":"Graeff RG, Shoenfeld RI (1970) Tryptaminergic mechanisms in punished and nonpunished behavior. J Pharmacol Exp Ther 173:277?283","journal-title":"J Pharmacol Exp Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0091-3057(82)90340-9","volume":"17","author":"SJ Grant","year":"1982","unstructured":"Grant SJ, Redmond DE (1982) Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome. Pharmacol Biochem Behav 17:655?658","journal-title":"Pharmacol Biochem Behav"},{"key":"CR20","first-page":"495","volume-title":"Factors affecting the action of narcotics","author":"JT Huang","year":"1978","unstructured":"Huang JT, Yano I, Takemori AE (1978) Effect of various central biogenic amine-modifiers and ambient temperature on the naloxone-induced jumping in morphine-dependent mice. In: Adler ML, Manara L, Samanin R (eds) Factors affecting the action of narcotics. Raven Press, New York, pp 495?509"},{"key":"CR21","first-page":"444","volume":"146","author":"F Huidobro","year":"1963","unstructured":"Huidobro F, Contreras E, Croxatto R (1963) Studies on morphine. III. Action of metabolic precursors to serotonin and noradrenaline and related substances on the ?abstinence syndrome? to morphine in white mice. Arch Int Pharmacodyn 146:444?454","journal-title":"Arch Int Pharmacodyn"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(76)90012-1","volume":"37","author":"T Karasawa","year":"1976","unstructured":"Karasawa T, Furukawa K, Yoshida K, Shimizu, M (1976) Effect of theophylline on monoamine metabolism in the rat brain. Eur J Pharmacol 37:97?104","journal-title":"Eur J Pharmacol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(87)90220-6","volume":"28","author":"MS Kleven","year":"1987","unstructured":"Kleven MS, Sparber SB (1987) Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine. Pharmacol Biochem Behav 28:235?241","journal-title":"Pharmacol Biochem Behav"},{"key":"CR24","first-page":"273","volume":"248","author":"MS Kleven","year":"1989","unstructured":"Kleven MS, Sparber SB (1989) Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine. J Pharmacol Exp Ther 248:273?277","journal-title":"J Pharmacol Exp Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1471-4159.1983.tb09064.x","volume":"41","author":"MS Kleven","year":"1983","unstructured":"Kleven MS, Dwoskin LP, Sparber SB (1983) Pharmacological evidence for the existence of multiple functional pools of brain serotonin: analysis of brain perfusate from conscious rats. J Neurochem 41:1143?1149","journal-title":"J Neurochem"},{"key":"CR26","first-page":"133","volume":"228","author":"I Lucki","year":"1984","unstructured":"Lucki I, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists on two behavioral models of serotonin, activation in the rat. J Pharmacol Exp. Ther 228:133?139","journal-title":"J Pharmacol Exp. Ther"},{"key":"CR27","first-page":"20","volume":"178","author":"Y Maruyama","year":"1971","unstructured":"Maruyama Y, Hayashi G, Smits SE, Takemori AE (1971) Studies on the relationship between 5-hydroxytryptamine turnover in brain and tolerance and physical dependence in mice. J Pharmacol Exp Ther 178:20?29","journal-title":"J Pharmacol Exp Ther"},{"key":"CR28","first-page":"1","volume":"236","author":"BS Neal","year":"1986","unstructured":"Neal BS, Sparber SB (1986) Mianserin, attenuates naloxone-precipitated withdrawal in rats acutely or chronically dependent upon morphine. J Pharmacol Exp Ther 236:1?9","journal-title":"J Pharmacol Exp Ther"},{"key":"CR29","first-page":"764","volume":"226","author":"JF Reinhard Jr","year":"1983","unstructured":"Reinhard JF Jr, Galloway MP, Roth RH (1983) Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine. J Pharmacol Exp Ther 226:764?769","journal-title":"J Pharmacol Exp Ther"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.2042-7158.1984.tb02995.x","volume":"36","author":"S Romandini","year":"1984","unstructured":"Romandini S, Cervo L, Samanin R (1984) Evidence that drugs increasing 5-hydroxytryptamine transmission block jumping but not wet dog shakes in morphine-abstinent rats: a comparison with clonidine. J Pharm Pharmacol 36:68?70","journal-title":"J Pharm Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0024-3205(80)90464-6","volume":"27","author":"R Saminin","year":"1980","unstructured":"Saminin R, Cervo L, Rochat, C, Poggesi E, Mennini T (1980) Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: relation to blockade of naloxone precipitated jumping by serotonin agonists. Life Sci 27:1141?1146","journal-title":"Life Sci"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0024-3205(70)90092-5","volume":"9","author":"AS Schwartz","year":"1970","unstructured":"Schwartz AS, Eidelberg E (1970) Role of biogenic amines in morphine dependence in the rat. Life Sci 9:613?624","journal-title":"Life Sci"},{"key":"CR33","first-page":"80","volume-title":"The effects of foods and drugs on the development and function of the nervous system","author":"SB Sparber","year":"1980","unstructured":"Sparber SB (1980) Use of learned behavior in testing for neurotoxicity. In: Gryder RM, Frankos VH (eds) The effects of foods and drugs on the development and function of the nervous system. HHS Publication (FDA), Washington, DC, pp 80?107"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0091-3057(78)90292-7","volume":"9","author":"SB Sparber","year":"1978","unstructured":"Sparber SB, Meyer DR (1978) Clonidine antagonizes naloxoneinduced supression of conditioned behavior and body weight loss in morphine dependent rats. Pharmacol Biochem Behav 9:319?325","journal-title":"Pharmacol Biochem Behav"},{"key":"CR35","first-page":"201","volume-title":"Statistical principles in experimental design","author":"BJ Winer","year":"1971","unstructured":"Winer BJ (1971) Statistical principles in experimental design. McGraw-Hill, New York, pp 201?204"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0024-3205(74)90345-2","volume":"15","author":"DT Wong","year":"1974","unstructured":"Wong DT, Horng JS, Bymaster, FP, Molloy BB (1974) A selective inhibitor of serotonin uptake: Lilly 110140,3-(trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci 15:471?479","journal-title":"Life Sci"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0028-3908(83)90123-5","volume":"22","author":"CY Yap","year":"1983","unstructured":"Yap CY, Taylor DA (1983) Involvement of 5-HT2 receptors in the wet-dog shake behaviour, induced by 5-hydroxytryptophan in the rat. Neuropharmacology 22:801?804","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00444696.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00444696\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00444696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T01:24:51Z","timestamp":1554341091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00444696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["BF00444696"],"URL":"https:\/\/doi.org\/10.1007\/bf00444696","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}